| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 219 | 21.241 | 14.557 | 1.500 | 16.767 | 56.070 | 59.083 | 60.112 |
| Total Income - EUR | - | - | 219 | 21.324 | 14.630 | 1.608 | 16.806 | 56.169 | 60.368 | 60.140 |
| Total Expenses - EUR | - | - | 115 | 16.355 | 15.265 | 8.308 | 30.187 | 47.721 | 36.560 | 49.405 |
| Gross Profit/Loss - EUR | - | - | 104 | 4.970 | -635 | -6.700 | -13.381 | 8.448 | 23.808 | 10.735 |
| Net Profit/Loss - EUR | - | - | 98 | 4.331 | -1.073 | -6.746 | -13.885 | 6.755 | 20.513 | 9.275 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biotek Sinergo Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 1.053 | 1.722 | 1.780 | 2.586 | 2.177 | 6.182 | 36.755 |
| Current Assets | - | - | 148 | 3.800 | 2.638 | 10.625 | 20.699 | 71.401 | 41.386 | 19.655 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 1.894 | 10.579 | 17.095 | 58.925 | 40.628 | 13.136 |
| Cash | - | - | 148 | 3.800 | 744 | 45 | 3.604 | 12.476 | 758 | 6.519 |
| Shareholders Funds | - | - | 141 | 4.469 | 3.309 | -3.500 | -17.307 | -10.606 | 9.944 | 19.163 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 7 | 472 | 1.058 | 8.183 | 40.970 | 84.184 | 28.782 | 37.263 |
| Income in Advance | - | - | 0 | 0 | 0 | 7.721 | 0 | 0 | 8.843 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2399 - 2399" | |||||||||
| CAEN Financial Year |
2399
|
|||||||||
Comments - Biotek Sinergo Srl